You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 329 Prolonged overall survival (OS) in patients with metastatic colorectal cancer (mCRC) in SPICE, a phase I study of enadenotucirev in combination with nivolumab

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
329 Prolonged overall survival (OS) in patients with metastatic colorectal cancer (mCRC) in SPICE, a phase I study of enadenotucirev in combination with nivolumab

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020175015
Dec 202067023
Jan 20211001
Feb 20211802
Mar 20214206
Apr 20211004
May 20214014
Jun 2021003
Jul 2021008
Aug 2021007
Sep 2021004
Oct 202144020
Nov 202122018
Dec 20211600
Jan 20227802
Feb 20223001
Mar 20223604
Apr 20223805
May 20224203
Jun 20222803
Jul 20222400
Aug 20221801
Sep 20222803
Oct 20223000
Nov 20222201
Dec 20222203
Jan 20231402
Feb 20231800
Mar 20231600
Apr 20231405
May 20231201
Jun 20231601
Jul 20232607
Aug 20231602
Sep 2023200
Oct 20231002
Nov 20232401
Dec 20234401
Jan 2024400
Feb 20241800
Mar 20241401
Apr 20241001
May 20242200
Jun 20243705
Jul 20241600
Aug 20242400
Sep 20241804
Oct 20242601
Nov 20241603
Dec 20242901
Jan 20251005
Feb 2025001
Mar 2025001
Apr 2025002
May 2025003
Jun 2025104
Total12610205